XERS SG&A Expense Growth
Xeris Biopharma Holdings Inc · SG&A Expense Growth
XERS SG&A Expense Growth
Latest reported11.56%period ending
XERS FY SG&A Growth (YoY) (0.00% → 11.56%)
Latest values, visible window
High-resolution chart · PNG
XERS sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 11.5555% | |
| 11.9005% | |
| 6.0619% | |
| 9.5666% | |
| 70.5067% | |
| 16.9217% | |
| 198.6833% | |
| 163.4186% | |
| 97.4138% | |
| 0% |